Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements - Summary of Impact of Revision on Stockholders' Equity (Deficit) (Parenthetical) (Details)

v3.21.4
Restatement of Previously Issued Financial Statements - Summary of Impact of Revision on Stockholders' Equity (Deficit) (Parenthetical) (Details) - shares
3 Months Ended 6 Months Ended
Mar. 31, 2021
Jun. 30, 2021
Number of sale units 2,760 2,760
Common Stock    
Number of sale units 27,600,000 27,600,000
Warrants | Private Placement    
Number of sale units 7,270,000 7,270,000